Skip to main content
Advanced Technical In the Industry Vocabulary Test

blood-brain barrier

Selective barrier protecting the brain from toxins and infections, immature in newborns affecting drug penetration and infection risk.

Full Definition

The blood-brain barrier (BBB) is a highly selective semipermeable membrane barrier that separates circulating blood from the brain and extracellular fluid in the central nervous system. In neonates, particularly preterm infants, the blood-brain barrier is immature and more permeable than in older children and adults. This immaturity has significant clinical implications: it increases vulnerability to central nervous system infections and allows certain medications and toxins to cross more readily into brain tissue. The increased permeability also contributes to the risk of bilirubin crossing into brain tissue, potentially causing kernicterus. Understanding BBB development is crucial for medication dosing and infection management in neonatal care.

Usage

Usage note: Important concept for understanding medication pharmacokinetics and infection patterns in neonates. Often abbreviated as BBB.

In Context

  • "The immature blood-brain barrier in preterm infants increases susceptibility to meningitis." — Infection control protocol
  • "Antibiotic selection considered the enhanced blood-brain barrier penetration in neonates." — Pharmacology consultation

Also known as

BBB

Don't confuse with

blood-CSF barrier placental barrier

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON